Comparison of alfaxalone and propofol on haematological and serum biochemical variables in cats undergoing radiotherapy with sevoflurane maintenance.
Heinz bodies
anaemia
anaesthetic
feline
repeated induction agent
Journal
Veterinary anaesthesia and analgesia
ISSN: 1467-2995
Titre abrégé: Vet Anaesth Analg
Pays: United States
ID NLM: 100956422
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
11
01
2022
revised:
30
10
2022
accepted:
21
11
2022
pubmed:
10
2
2023
medline:
3
3
2023
entrez:
9
2
2023
Statut:
ppublish
Résumé
To evaluate effects of repeated alfaxalone or propofol administration on haematological and serum biochemical variables in cats undergoing radiotherapy. Prospective, block-randomized, clinical trial. A group of 39 client-owned cats. After butorphanol (0.2 mg kg At baseline there were no significant differences in signalment or blood variables between groups. A significant decrease in haematocrit of 2.3% ± 0.77 (p = 0.02) between T1-T6 and T1-T10 [mean 4.1% (± 0.78, p < 0.0001)] was detected, with a significant increase in haematocrit of 2.1% ± 0.80 (p = 0.046) between T6-T21 and 4.0% ± 0.8 (p < 0.001) between T10-T21. Heinz body score significantly increased by 1.86 ± 0.616 (p = 0.013) between T1-T10. In the propofol group, reticulocytes increased significantly between T1-T6 [mean 23,090 μL Haematocrit decreased in both groups with recovery after 3 weeks. Repeated alfaxalone and propofol administration was not associated with marked haematological or serum biochemistry changes.
Identifiants
pubmed: 36759290
pii: S1467-2987(22)00210-0
doi: 10.1016/j.vaa.2022.11.010
pii:
doi:
Substances chimiques
Propofol
YI7VU623SF
Sevoflurane
38LVP0K73A
alphaxalone
BD07M97B2A
Pregnanediones
0
Types de publication
Randomized Controlled Trial, Veterinary
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
146-156Informations de copyright
Copyright © 2022 Association of Veterinary Anaesthetists and American College of Veterinary Anesthesia and Analgesia. Published by Elsevier Ltd. All rights reserved.